CURASAN AG overview

DGAP-News: curasan AG / Key word(s): AGM/EGM curasan AG: Annual General Meeting 2019 26.06.2019 / 18:15 The issuer is solely responsible for the content of this announcement. Shareholders approve necessary capital measures Reverse stock split in the ration 3:1 Capital increase with subscription right up to EUR 2.938.427 Kleinostheim, 26 June 2019 - curasan AG, Germany, a leading specialist for medical products in the field of orthobiologics, held its Annual General Meeting today. In his speech...

DGAP-News: curasan AG / Key word(s): Quarterly / Interim Statement curasan increases sales considerably in the first quarter 23.05.2019 / 08:02 The issuer is solely responsible for the content of this announcement. - Net group revenues with EUR 1.7 million 9 % above previous year - Turnover in the Middle East recovers and exceeds previous year significantly - Outlook for full year 2019 confirmed Kleinostheim, 23 May 2019 - curasan AG, Germany, a leading specialist for medical products in the...

DGAP-News: curasan AG / Key word(s): Annual Results curasan must cope with significant setbacks in international sales in 2018 13.05.2019 / 19:13 The issuer is solely responsible for the content of this announcement. Net sales reduced by 14.0 Percent to EUR 5.8 million Export sales suffer from geopolitical development EBITDA with EUR -3.8 million clearly below previous year Extensive conversion of the company planned Kleinostheim, 13 May 2019 - curasan AG, Germany, a leading specialist for...

DGAP-Ad-hoc: curasan AG / Key word(s): Miscellaneous curasan AG: Volume of convertible bond, further finance commitment by investor, resolution proposals on reduction of the share capital and subsequent capital increase with subscription rights, possible resignation of Board members and audit certificate 02-May-2019 / 18:43 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely...

DGAP-News: curasan AG / Key word(s): AGM/EGM curasan AG: Extraordinary General Meeting 30.01.2019 / 07:36 The issuer is solely responsible for the content of this announcement. - Shareholders approve authorization to issue convertible bonds - Election of Isabella de Krassny to the Supervisory Board - Presentation of the strategic realignment of curasan AG Kleinostheim, 30 January 2019 - curasan AG, Germany, a leading specialist for medical products in the field of orthobiologics, has held an...

DGAP-News: curasan AG / Key word(s): Regulatory Approval curasan AG: Market clearance for Osbone in Japan 24.01.2019 / 15:35 The issuer is solely responsible for the content of this announcement. - Clearance of synthetic bone graft material Osbone - Expanded product portfolio for the Japanese market Kleinostheim, 24 January 2019 - curasan AG, Germany, a leading specialist for medical products in the field of orthobiologics, has received news that the Japanese Pharmaceutical and Medical Devices...

DGAP-News: curasan AG / Key word(s): 9 Month figures curasan battles economy political headwinds despite strong domestic demand 22.11.2018 / 07:58 The issuer is solely responsible for the content of this announcement. - Net consolidated sales of the first nine months decline to EUR 4.4 million - Sales development of the regions MENA and USA below expectations - Positive impulses from Germany and the Asian markets Kleinostheim, 22 November 2018 - curasan AG (ISIN DE0005494538), a leading...

DGAP-News: curasan AG / Key word(s): Half Year Results curasan returns to growth with a 16 percent increase in sales compared to previous year's quarter 23.08.2018 / 08:10 The issuer is solely responsible for the content of this announcement. - Net Group sales in the first half of the year at EUR 3.4 million, at the previous year's level - Strengthened partner base continues to materialize with growth of +20 % in German and +50 % in Asian market - Guidance for full year 2018 confirmed...